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Distribution of complement regulatory
proteins, decay-accelerating factor,
CD59/homologous restriction factor 20 and
membrane cofactor protein in human
colorectal adenoma and cancer.∗
Hiroshi Inoue, Motowo Mizuno, Tokurou Uesu, Toru Ueki, and Takao Tsuji
Abstract
To clarify the events related to complement-mediated immune responses in human colorec-
tal cancers, we immunohistochemically examined the distribution of decay-accelerating factor
(DAF), CD59/homologous restriction factor 20 (HRF20), membrane cofactor protein (MCP) and
terminal complement complex (TCC) in human colorectal adenomas and cancers, and then com-
pared the findings with their distribution in normal colonic mucosa. In the normal mucosa, TCC
was not present on epithelial cells. Whereas DAF and CD59/HRF20 were present only occasion-
ally on the apical surfaces of normal epithelial cells, MCP was diffusely distributed on the basolat-
eral surfaces of most epithelial cells of the colon. These findings suggest that MCP has a primary
role in the regulation of complement activation on these cells. In adenoma cells, the expression
of both DAF and CD59/HRF20 was enhanced. In cancer cells, the expression of CD59/HRF20
and MCP was diminished, whereas DAF expression was markedly enhanced. Since DAF was
frequently stained in the lumen of the cancer glands, it was suggested that DAF was released into
the colonic lumen in patients with colorectal cancer.
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